These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
13. Pharmacochemical profile of iopromide. Muetzel W; Speck U AJNR Am J Neuroradiol; 1983; 4(3):350-2. PubMed ID: 6410742 [TBL] [Abstract][Full Text] [Related]
14. Iohexol versus metrizamide for cervical myelography: double-blind trial. Gebarski SS; Gabrielsen TO; Knake JE; Latack JT; Yang PJ; Hoff JT AJNR Am J Neuroradiol; 1985; 6(6):923-6. PubMed ID: 3934930 [TBL] [Abstract][Full Text] [Related]
15. Iotrol, a new water-soluble non-ionic dimeric contrast medium for intrathecal use. Hammer B; Deisenhammer E Neuroradiology; 1985; 27(4):337-41. PubMed ID: 3900800 [TBL] [Abstract][Full Text] [Related]
16. Neurotoxicity of iohexol: a new nonionic contrast medium. Bryan RN; Centeno RS; Hershkowitz N; Poelstra RJ; Osato MS Radiology; 1982 Nov; 145(2):379-82. PubMed ID: 7134441 [TBL] [Abstract][Full Text] [Related]
17. Clinical trial of iotrol for lumbar myelography. Skutta T; Vogelsang H; Galanski M; Hammer B; Weinmann HJ AJNR Am J Neuroradiol; 1983; 4(3):302-3. PubMed ID: 6410726 [TBL] [Abstract][Full Text] [Related]
18. Arachnoiditis from myelography with iopamidol, metrizamide, and iocarmate compared in the animal model. Haughton VM; Ho KC Invest Radiol; 1980; 15(6 Suppl):S267. PubMed ID: 7203934 [TBL] [Abstract][Full Text] [Related]
19. Proteinuria following nephroangiography. VII. Comparison between ionic monomeric, monoacidic dimeric and non-ionic contrast media in the dog. Törnquist C; Almén T; Golman K; Holtås S Acta Radiol Suppl; 1980; 362():49-52. PubMed ID: 6267893 [TBL] [Abstract][Full Text] [Related]
20. Iopamidol vs. metrizamide myelography: clinical comparison of side effects. Trevisan C; Malaguti C; Manfredini M; Tampieri D AJNR Am J Neuroradiol; 1983; 4(3):306-8. PubMed ID: 6410728 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]